BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31381408)

  • 1. Patient Population Size And Drug Prices.
    Liang X
    Health Aff (Millwood); 2019 Aug; 38(8):1409. PubMed ID: 31381408
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme.
    Karnon J; Edney L; Sorich M
    Aust Health Rev; 2017 Mar; 41(1):1-6. PubMed ID: 26954612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of external price referencing of pharmaceuticals in Middle East countries.
    Kaló Z; Alabbadi I; Al Ahdab OG; Alowayesh M; Elmahdawy M; Al-Saggabi AH; Tanzi VL; Al-Badriyeh D; Alsultan HS; Ali FM; Elsisi GH; Akhras KS; Vokó Z; Kanavos P
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):993-8. PubMed ID: 26088919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Price comparison of high-cost originator medicines in European countries.
    Vogler S; Zimmermann N; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of studies reporting actual prices for medicines.
    Mardetko N; Kos M; Vogler S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):159-179. PubMed ID: 30468097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
    Russo G; McPake B
    Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determinants of pricing in pharmaceuticals: are US prices really so high?
    Cabrales A; Jiménez-Martín S
    Health Econ; 2013 Nov; 22(11):1377-97. PubMed ID: 23303712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaceutical pricing; what is reasonable?].
    Versteegh MM
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prices of 18 new drug formulations are capped in India.
    Travasso C
    BMJ; 2015 Nov; 351():h6006. PubMed ID: 26553651
    [No Abstract]   [Full Text] [Related]  

  • 10. How cheap are Canada's drugs really?
    Hollis A
    J Pharm Pharm Sci; 2004 Jun; 7(2):215-6. PubMed ID: 15367378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on the implications of external price referencing of pharmaceuticals in Middle East countries.
    Carapinha JL
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):11-4. PubMed ID: 26707161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of drug coupons.
    Grande D
    JAMA; 2012 Jun; 307(22):2375-6. PubMed ID: 22692167
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug pricing in AFP--how much does a drug cost?
    Siwek J
    Am Fam Physician; 2010 Jan; 81(2):125. PubMed ID: 20082507
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?
    Mestre-Ferrandiz J; Zozaya N; Alcalá B; Hidalgo-Vega Á
    Pharmacoeconomics; 2018 Dec; 36(12):1407-1420. PubMed ID: 30198061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High prices and low clinical benefit: anomalies of the drug market].
    Pagano E
    Epidemiol Prev; 2018; 42(1):92-93. PubMed ID: 29506372
    [No Abstract]   [Full Text] [Related]  

  • 17. Sanofi vows to limit price hikes- but will it make much difference?
    Kacik A
    Mod Healthc; 2017 May; 47(20):12. PubMed ID: 30496647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to: Comment on the implications of external price referencing of pharmaceuticals in Middle East countries.
    Kaló Z; Vokó Z; Akhras KS; Kanavos P
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):15-6. PubMed ID: 26707267
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer Drugs: An International Comparison of Postlicensing Price Inflation.
    Savage P; Mahmoud S; Patel Y; Kantarjian H
    J Oncol Pract; 2017 Jun; 13(6):e538-e542. PubMed ID: 28605615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.